Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Vaccines
Vaccines
Page 8 of 31
Success
Gen Z needs brand-new skills to climb to the C-suite: ‘What got me here will not get them there,’ says health care CEO
By
Jane Thier
June 2, 2023
Leadership
GSK’s CEO says you need thick skin if you’re going to step into the C-suite
By
Fortune Editors
May 31, 2023
Health
Sen. Feinstein’s high-stakes battle with shingles shows just how serious the disease can be. Learn how to spot the symptoms and stay safe
By
Erin Prater
May 20, 2023
Health
That respiratory infection you had that wasn’t COVID has never had a vaccine—until now
By
Annette Regan
and
The Conversation
May 10, 2023
Aging Well
Over 50? It’s time to talk about shingles. Here’s everything you need to know
By
Alex Vance
April 26, 2023
Health
Moderna eyes human testing of mpox, bird flu vaccines this year: ‘They’re really for public health’
By
Angelica Pebbles
and
Bloomberg
March 6, 2023
Aging Well
An FDA panel has endorsed 2 RSV vaccines for older Americans. Here’s when they might be available
By
Erin Prater
March 2, 2023
Aging Well
Pfizer’s RSV vaccine just won an FDA panel’s backing for safety in older people. It’s a market that will be worth up to $10 billion in a decade
By
Nacha Cattan
and
Bloomberg
February 28, 2023
Health
One of Biden’s top COVID advisors believes vaccine critics ‘quietly’ got jabbed on the side
By
Eleanor Pringle
February 8, 2023
Success
Bill Gates would rather invest in vaccines than go to Mars—even after becoming the ‘bogeyman’ of anti-vax conspiracy theories
By
Chloe Taylor
February 3, 2023
Health
Americans keep refusing to vaccinate their kindergarteners
By
Mike Stobbe
and
The Associated Press
January 12, 2023
Family
Pfizer’s maternal RSV vaccine could protect infants from the virus
By
L'Oreal Thompson Payton
November 1, 2022
Health
The most common side effects to expect from the Omicron COVID booster
By
Chloe Taylor
September 15, 2022
Health
An HIV vaccine is ‘more than five years away,’ former AIDS Society head warns
By
Bloomberg
September 14, 2022
Health
Pfizer-BioNTech ‘surprised’ by Moderna lawsuit alleging they copied COVID-19 vaccine technology
By
Chloe Taylor
August 26, 2022
Most Popular
Real Estate
The 'Great Housing Reset' is coming: Income growth will outpace home-price growth in 2026, Redfin forecasts
By
Nino Paoli
Politics
Supreme Court to reconsider a 90-year-old unanimous ruling that limits presidential power on removing heads of...
By
Mark Sherman
and
The Associated Press
AI
Nvidia CEO says data centers take about 3 years to construct in the U.S., while in China 'they can build a hospital in...
By
Nino Paoli